SHBI Stock Analysis: Shore Bancshares | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 774m USD | 12M Return: 39.5% | US8251071051 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.01M
EPS Trend: 96.0%
Qual. Beats: 2
Rev. Trend: 82.9%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Shore Bancshares, Inc. (NASDAQ: SHBI) is a bank holding company that operates Shore United Bank, N.A., headquartered in Easton, Maryland, and founded in 1876. The company provides a full suite of consumer and commercial banking products and services, including deposit products such as checking, savings, money market, and IRA certificates of deposit, as well as commercial loans, residential mortgage and construction loans, and consumer lending products like home equity, auto, and personal lines of credit. Beyond core banking, Shore Bancshares offers trust and wealth management services, treasury management solutions, merchant card processing, remote deposit capture, ACH origination, and digital banking channels, serving individuals, businesses, and other organizations in the United States.
As a small-cap regional bank within the Financials sector, Shore Bancshares operates a traditional community banking model in which net interest income (the difference between interest earned on loans and interest paid on deposits) is typically the primary revenue driver. Regional banks of this size generally depend on local deposit gathering and relationship-based lending, with wealth management and treasury services providing non-interest income to diversify the revenue mix.
- Net interest margin compresses as Fed cuts rates
- Commercial real estate loan losses pressure earnings
- Deposit growth and loan demand expand across Mid-Atlantic markets
| Net Income: 66.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.60 > 1.0 |
| NWC/Revenue: -1.28k% < 20% (prev -1.46k%; Δ 188.6% < -1%) |
| CFO/TA 0.01 > 3% & CFO 90.1m > Net Income 66.2m |
| Net Debt (-825.9m) to EBITDA (102.0m): -8.10 < 3 |
| Current Ratio: 0.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (33.5m) vs 12m ago 0.22% < -2% |
| Gross Margin: 66.51% > 18% (prev 61.92%; Δ 4.59% > 0.5%) |
| Asset Turnover: 5.68% > 50% (prev 5.57%; Δ 0.11% > 0%) |
| Interest Coverage Ratio: 0.80 > 6 (EBIT TTM 87.6m / Interest Expense TTM 109.9m) |
| A: -0.72 (Total Current Assets 986.3m - Total Current Liabilities 5.40b) / Total Assets 6.15b |
| B: 0.04 (Retained Earnings 260.8m / Total Assets 6.15b) |
| C: 0.01 (EBIT TTM 87.6m / Avg Total Assets 6.09b) |
| D: 0.11 (Book Value of Equity 616.1m / Total Liabilities 5.54b) |
| Altman-Z'' = -4.35 = D |
| DSRI: 0.98 (Receivables 20.0m/19.8m, Revenue 346.1m/336.2m) |
| GMI: 0.93 (GM 61.92% / 66.51%) |
| AQI: 0.90 (AQ_t 0.83 / AQ_t-1 0.92) |
| SGI: 1.03 (Revenue 346.1m / 336.2m) |
| TATA: -0.00 (NI 66.2m - CFO 90.1m) / TA 6.15b) |
| Beneish M = -3.14 (Cap -4..+1) = AA |
As of September 27, 2026, the stock is trading at USD 23.01 with a total of 224,883 shares traded. Over the past week, the price has changed by -0.95%, over one month by +0.23%, over three months by +1.55% and over the past year by +39.51%.
Current recommended Stop Loss: 22.30 (which is 3.1% or 1.6 ATR below the current price).
Shore Bancshares has received a consensus analysts rating of 3.67. Therefore, it is recommended to hold SHBI.
- StrongBuy: 0
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 25.8 | 11.9% |
P/E Trailing = 11.7716
P/E Forward = 10.0908
P/S = 3.3617
P/B = 1.2581
P/EG = 1.1676
Revenue TTM = 346.1m USD
EBIT TTM = 87.6m USD
EBITDA TTM = 102.0m USD
Long Term Debt = 89.2m USD (from longTermDebt, last quarter)
Short Term Debt = 10.2m USD (from shortTermDebt, last quarter)
Debt = 109.5m USD (from shortLongTermDebtTotal, last quarter) + Leases 10.2m
Net Debt = -825.9m USD (calculated: Debt 109.5m - CCE 935.5m)
Enterprise Value = 773.9m USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 0.80 (Ebit TTM 87.6m / Interest Expense TTM 109.9m)
EV/FCF = 8.88x (Enterprise Value 773.9m / FCF TTM 87.2m)
FCF Yield = 11.26% (FCF TTM 87.2m / Enterprise Value 773.9m)
FCF Margin = 25.19% (FCF TTM 87.2m / Revenue TTM 346.1m)
Net Margin = 19.12% (Net Income TTM 66.2m / Revenue TTM 346.1m)
Gross Margin = 66.51% ((Revenue TTM 346.1m - Cost of Revenue TTM 115.9m) / Revenue TTM)
Gross Margin QoQ = 70.13% (prev 69.73%)
Tobins Q-Ratio = 0.13 (Enterprise Value 773.9m / Total Assets 6.15b)
Interest Expense / Debt = 100.3% (Interest Expense 109.9m / Debt 109.5m)
Taxrate = 24.45% (21.4m / 87.6m)
NOPAT = 66.2m (EBIT 87.6m * (1 - 24.45%))
Current Ratio = 0.18 (Total Current Assets 986.3m / Total Current Liabilities 5.40b)
Debt / Equity = 0.18 (Debt 109.5m / totalStockholderEquity, last quarter 616.1m)
Debt / EBITDA = -8.10 (Net Debt -825.9m / EBITDA 102.0m)
Debt / FCF = -9.47 (Net Debt -825.9m / FCF TTM 87.2m)
Total Stockholder Equity = 596.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.09% (Net Income 66.2m / Total Assets 6.15b)
RoE = 11.10% (Net Income TTM 66.2m / Total Stockholder Equity 596.5m)
RoCE = 12.78% (EBIT 87.6m / Capital Employed (Equity 596.5m + L.T.Debt 89.2m))
RoIC = 8.89% (NOPAT 66.2m / Invested Capital 744.6m)
WACC = 7.36% (E(773.9m)/V(883.5m) * Re(8.40%) + (debt cost/tax rate unavailable))
Discount Rate = 8.40% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 93.58 | Cagr: 0.36%
[DCF] Terminal Value 77.97% ; FCFF base≈72.0m ; Y1≈82.5m ; Y5≈121.4m
[DCF] Fair Price = 79.49 (EV 1.83b - Net Debt -825.9m = Equity 2.65b / Shares 33.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 96.01 | EPS CAGR: 35.61% | SUE: 3.00 | # QB: 2
Revenue Correlation: 82.85 | Revenue CAGR: 17.51% | SUE: 0.64 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.54 | Chg30d=-2.27% | Revisions=+50% | Analysts=4
EPS current Year (2026-12-31): EPS=2.17 | Chg30d=+1.17% | Revisions=+57% | GrowthEPS=+21.6% | GrowthRev=+8.7%
EPS next Year (2027-12-31): EPS=2.27 | Chg30d=+0.74% | Revisions=+57% | GrowthEPS=+4.9% | GrowthRev=+3.6%
[Analyst] Revisions Ratio: +79% (up=11, down=0)